UKBizDB.co.uk

DVOSS & CHELSY HEALTHCARE LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Dvoss & Chelsy Healthcare Limited. The company was founded 11 years ago and was given the registration number 08447004. The firm's registered office is in LONDON. You can find them at 14a3 Parsons House, Claybrook Road, London, . This company's SIC code is 86900 - Other human health activities.

Company Information

Name:DVOSS & CHELSY HEALTHCARE LIMITED
Company Number:08447004
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:15 March 2013
Industry Codes:
  • 86900 - Other human health activities

Office Address & Contact

Registered Address:14a3 Parsons House, Claybrook Road, London, W6 8NB
Country Origin:
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
14a3 Parsons House, Claybrook Road, London, England, W6 8NB

Director15 March 2013Active

People with Significant Control

Mr Sherwin Villegas
Notified on:01 June 2017
Status:Active
Date of birth:March 1975
Nationality:British
Country of residence:England
Address:14a3, Claybrook Road, London, England, W6 8NB
Nature of control:
  • Ownership of shares 75 to 100 percent
  • Ownership of shares 75 to 100 percent as trust
  • Ownership of shares 75 to 100 percent as firm
  • Voting rights 75 to 100 percent
  • Voting rights 75 to 100 percent as trust
  • Voting rights 75 to 100 percent as firm
  • Right to appoint and remove directors
  • Right to appoint and remove directors as trust
  • Right to appoint and remove directors as firm

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (0 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (2 months remaining)

Copyright © 2025. All rights reserved.